Selecting Immune Checkpoint Inhibitor Side Effects for Real-Time Monitoring in Routine Cancer Care: A Modified Delphi Study
We developed a consumer- and clinician-driven prioritized list of 36 ICI side effects to include in future ePRO systems. This process highlights the importance of broad stakeholder engagement in side-effect selection and rigorously identifying clinically important side effects to ensure content validity and clinical utility.
Authors
- Julia Lai‐Kwon (ORCID: https://orcid.org/0000-0002-5388-1695)
- Iris Zhang (ORCID: https://orcid.org/0009-0003-3800-658X)
- Michael Jefford (ORCID: https://orcid.org/0000-0002-8792-7807)
- Claudia Rutherford (ORCID: https://orcid.org/0000-0002-4637-4572)
- Stephanie Best (ORCID: https://orcid.org/0000-0002-1107-8976)
Institutions
- The University of Sydney (AU)
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
- Victorian Comprehensive Cancer Centre (AU)
- Murdoch Children's Research Institute (AU)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1200/op.24.00037
- Citations
- 4
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 1.13